{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:09:58Z","timestamp":1792548598775,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-026-00853-w","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:06:56Z","timestamp":1774325216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and efficacy of apixaban versus enoxaparin in gynecologic cancer patients undergoing open surgery: an open-label randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Soheila","family":"Aminimoghaddam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Mohazzab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghayeh","family":"Pourali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1640-7348","authenticated-orcid":false,"given":"Hoda","family":"Zendehdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"9","key":"853_CR1","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1097\/IGC.0000000000001111","volume":"27","author":"A Cohen","year":"2017","unstructured":"Cohen A, Lim CS, Davies AH. Venous thromboembolism in gynecological malignancy. Int J Gynecol Cancer. 2017;27(9):1970\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"853_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/IGC.0000000000000912","volume":"27","author":"A Graul","year":"2017","unstructured":"Graul A, Latif N, Zhang X, Dean LT, Morgan M, Giuntoli R, et al. Incidence of venous thromboembolism by type of gynecologic malignancy and surgical modality in the National Surgical Quality Improvement Program. Int J Gynecol Cancer. 2017;27(3):581\u20137.","journal-title":"Int J Gynecol Cancer"},{"issue":"16","key":"853_CR3","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.23.00294","volume":"41","author":"NS Key","year":"2023","unstructured":"Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update. J Clin Oncol. 2023;41(16):3063\u201371.","journal-title":"J Clin Oncol"},{"key":"853_CR4","doi-asserted-by":"publisher","first-page":"107602962211325","DOI":"10.1177\/10760296221132556","volume":"28","author":"ALM de Longo","year":"2022","unstructured":"de Longo ALM, de Oliveira Pereira RF, Agati LB, Ribeiro CM, Kawamura Suguiura GY, Cioni CH, et al. Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: V enous thromboembolism prophyl A xis after gyneco L ogical p E lvic cancer surgery with RI varoxaban versus enox A parin (VALERIA trial). Clin Appl Thromb Hemost. 2022;28:10760296221132556.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"853_CR5","doi-asserted-by":"publisher","first-page":"e208019","DOI":"10.1001\/jamanetworkopen.2020.8019","volume":"3","author":"E Diver","year":"2020","unstructured":"Diver E. Apixaban vs Enoxaparin for Postoperative Prophylaxis: Safety of an Oral Alternative for the Prevention of Venous Thromboembolism. JAMA Netw Open. 2020;3(6):e208019\u2013e.","journal-title":"JAMA Netw Open"},{"key":"853_CR6","doi-asserted-by":"publisher","first-page":"101535","DOI":"10.1016\/j.gore.2024.101535","volume":"56","author":"V Diamond","year":"2024","unstructured":"Diamond V, Gerber K, Merli G, Mercier R, Shafer A, Rosenblum N. Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center. Gynecol Oncol Rep. 2024;56:101535.","journal-title":"Gynecol Oncol Rep"},{"key":"853_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ygyno.2024.01.039","volume":"183","author":"A Knisely","year":"2024","unstructured":"Knisely A, Iniesta MD, Batman S, Meyer LA, Soliman PT, Cain KE, et al. Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center. Gynecol Oncol. 2024;183:120\u20135.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"853_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/ijgc-2021-003006","volume":"32","author":"M Boo","year":"2022","unstructured":"Boo M, Sykes P, Simcock B. Use of direct oral anticoagulants for postoperative venous thromboembolism prophylaxis after surgery for gynecologic malignancies. Int J Gynecol Cancer. 2022;32(2):189\u201394.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"853_CR9","doi-asserted-by":"publisher","first-page":"109649","DOI":"10.1016\/j.ejso.2025.109649","volume":"51","author":"G Reis Romualdo","year":"2025","unstructured":"Reis Romualdo G, Soares Pinhati ME, Andrade Souza R, Lage Neves G, Batista C\u00e2ndido E. Lopes da Silva Filho A. Efficacy of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after gynecological cancer surgery: A systematic review and meta-analysis. Eur J Surg Oncol. 2025;51(6):109649.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"853_CR10","doi-asserted-by":"publisher","first-page":"e207410","DOI":"10.1001\/jamanetworkopen.2020.7410","volume":"3","author":"SR Guntupalli","year":"2020","unstructured":"Guntupalli SR, Brennecke A, Behbakht K, Tayebnejad A, Breed CA, Babayan LM, et al. Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial. JAMA Netw open. 2020;3(6):e207410\u2013e.","journal-title":"JAMA Netw open"},{"issue":"1","key":"853_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/AOG.0000000000001492","volume":"128","author":"EL Barber","year":"2016","unstructured":"Barber EL, Gehrig PA, Clarke-Pearson DL. Venous Thromboembolism in Minimally Invasive Compared With Open Hysterectomy for Endometrial Cancer. Obstet Gynecol. 2016;128(1):121\u20136.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"853_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ygyno.2021.12.011","volume":"164","author":"BE Swift","year":"2022","unstructured":"Swift BE, Maeda A, Bouchard-Fortier G. Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk? Gynecol Oncol. 2022;164(2):311\u20137.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"853_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-0038-1668581","volume":"40","author":"ALD Silva Filho","year":"2018","unstructured":"Silva Filho ALD, Santiago AE, Derchain SFM, Carvalho JP. Enhanced Recovery After Surgery (ERAS): New Concepts in the Perioperative Management of Gynecologic Surgery. Rev Bras Ginecol Obstet. 2018;40(8):433\u20136.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"4","key":"853_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb haemostasis: JTH. 2005;3(4):692\u20134.","journal-title":"J Thromb haemostasis: JTH"},{"issue":"10294","key":"853_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","volume":"398","author":"F Khan","year":"2021","unstructured":"Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64\u201377.","journal-title":"Lancet"},{"issue":"7","key":"853_CR16","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1097\/IGC.0000000000001041","volume":"27","author":"D Querleu","year":"2017","unstructured":"Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, et al. European Society of Gynaecological Oncology (ESGO) guidelines for ovarian cancer surgery. Int J Gynecol Cancer. 2017;27(7):1534\u201342.","journal-title":"Int J Gynecol Cancer"},{"key":"853_CR17","doi-asserted-by":"crossref","unstructured":"Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease\u2020. Ann Oncol. 2019;30(5):672\u2013705.","DOI":"10.1093\/annonc\/mdz062"},{"issue":"1","key":"853_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12\u201339.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"853_CR19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00428-018-2362-9","volume":"472","author":"D Cibula","year":"2018","unstructured":"Cibula D, P\u00f6tter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, et al. The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Virchows Arch. 2018;472(6):919\u201336.","journal-title":"Virchows Arch"},{"key":"853_CR20","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/occult.pdf. 2008."},{"issue":"4","key":"853_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/01.AOG.0000209465.55688.30","volume":"107","author":"JH Liu","year":"2006","unstructured":"Liu JH, Greer BE, Curtin J. ACOG Practice Bulletin# 65: management of endometrial cancer. Obstet Gynecol. 2006;107(4):952\u20133.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"853_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ygyno.2020.01.035","volume":"157","author":"A Sinno","year":"2020","unstructured":"Sinno A, Pinkerton J, Febbraro T, Jones N, Khanna N, Temkin S, et al. Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society. Gynecol Oncol. 2020;157(2):303\u20136.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"853_CR23","doi-asserted-by":"publisher","first-page":"e207410","DOI":"10.1001\/jamanetworkopen.2020.7410","volume":"3","author":"SR Guntupalli","year":"2020","unstructured":"Guntupalli SR, Brennecke A, Behbakht K, Tayebnejad A, Breed CA, Babayan LM, et al. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial. JAMA Netw Open. 2020;3(6):e207410.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"853_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ygyno.2020.07.096","volume":"159","author":"A Glickman","year":"2020","unstructured":"Glickman A, Brennecke A, Tayebnejad A, Matsuo K, Guntupalli SR, Sheeder J. Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery. Gynecol Oncol. 2020;159(2):476\u201382.","journal-title":"Gynecol Oncol"},{"key":"853_CR25","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/S0090-8258(21)00867-2","volume":"162","author":"K Cain","year":"2021","unstructured":"Cain K, Harrison R, Marten C, Fleming N, Taylor J. Comparison of out-of-pocket cost between apixaban and enoxaparin for extended-duration venous thromboembolism prophylaxis in gynecologic oncology patients. Gynecol Oncol. 2021;162:S118\u20139.","journal-title":"Gynecol Oncol"},{"key":"853_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2024.06.013","volume":"188","author":"KT Stewart","year":"2024","unstructured":"Stewart KT, Jafari H, Pattillo J, Santos J, Jao C, Kwok K, et al. Avoiding the needle: A quality improvement program introducing apixaban for extended thromboprophylaxis after major gynecologic cancer surgery. Gynecol Oncol. 2024;188:131\u20139.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"853_CR27","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1245\/s10434-024-15369-8","volume":"31","author":"J Floyd","year":"2024","unstructured":"Floyd J, Porragas-Paseiro H, Nguyen C, Moroney MR, Mastroyannis S, Guntupalli SR. Validation of the safety and efficacy of Apixaban as postoperative thromboembolism prophylaxis for patients with gynecologic malignancies. Ann Surg Oncol. 2024;31(8):5102\u201310.","journal-title":"Ann Surg Oncol"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-026-00853-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00853-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00853-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:23:52Z","timestamp":1774344232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-026-00853-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1186\/s12959-026-00853-w","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Iran University of Medical Sciences, under the code IR.IUMS.FMD.REC.1400.190. All the research methods used in a study involving human subjects followed the ethical guidelines outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided a written informed consent before participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The patient provided comprehensive consent to use their medical data anonymously for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}